James P. Maloney's most recent trade in Medifast Inc was a trade of 24,161 Common Stock done . Disclosure was reported to the exchange on March 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medifast Inc | James P. Maloney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 24,161 | 42,299 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.87 per share. | 13 Mar 2025 | 835 | 18,699 (0%) | 0% | 13.9 | 11,581 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.35 per share. | 13 Mar 2025 | 438 | 18,138 (0%) | 0% | 14.3 | 6,285 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.94 per share. | 13 Mar 2025 | 123 | 18,576 (0%) | 0% | 13.9 | 1,715 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 424 | 19,534 (0%) | 0% | 36.6 | 15,523 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 119 | 19,958 (0%) | 0% | 36.6 | 4,357 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.62 per share. | 15 Mar 2024 | 73 | 20,077 (0%) | 0% | 36.6 | 2,673 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 8,718 | 20,150 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Maloney P. James | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 2,328 | 12,080 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | P. James Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share. | 14 Feb 2024 | 648 | 11,432 (0%) | 0% | 52.7 | 34,137 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2023 | 3,574 | 10,779 (0%) | 0% | - | Common Stock | |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.50 per share. | 20 Jul 2023 | 1,027 | 9,752 (0%) | 0% | 94.5 | 97,052 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.50 per share. | 20 Jul 2023 | 115 | 7,205 (0%) | 0% | 94.5 | 10,868 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 4,574 | 7,320 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.46 per share. | 16 Mar 2023 | 123 | 2,821 (0%) | 0% | 104.5 | 12,849 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.75 per share. | 16 Mar 2023 | 75 | 2,746 (0%) | 0% | 102.7 | 7,706 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 174.44 per share. | 20 Jul 2022 | 115 | 2,944 (0%) | 0% | 174.4 | 20,061 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 1,281 | 3,134 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 180.52 per share. | 16 Mar 2022 | 75 | 3,059 (0%) | 0% | 180.5 | 13,539 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.00 per share. | 20 Jul 2021 | 115 | 1,853 (0%) | 0% | 277 | 31,855 | Common Stock |
| Medifast Inc | James P. Maloney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 776 | 1,968 (0%) | 0% | 0 | Common Stock |